Dermatological Abnormalities in Beta-thalassemia Major
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Beta-Thalassemia
Related studies linked through entity extraction aliases.
Resistance Exercise on Postprandial Hyperglycemia in Patients With B-thalassemia Exhibiting Resistance to Insulin
- Status
- COMPLETED
- Phase
- NA
Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients
- Status
- COMPLETED
- Phase
- PHASE2
Detection Of β-thalassemia Carriers In Assiut
- Status
- UNKNOWN
- Phase
- NA
SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias
- Status
- WITHDRAWN
- Phase
- PHASE2
the Efficacy and Safety of Sugammadex in Children 0-2 Years Old
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Early Check: Expanded Screening in Newborns
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Complications in Children With B- Thalassemia Major
- Status
- UNKNOWN
- Phase
- N/A
A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia
- Status
- TERMINATED
- Phase
- PHASE2
Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector
- Status
- UNKNOWN
- Phase
- NA
A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia
- Status
- COMPLETED
- Phase
- PHASE2
Thalassemia Treatment Based on the Stem Cell Technology
- Status
- UNKNOWN
- Phase
- NA
A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia
- Status
- COMPLETED
- Phase
- PHASE3
A Study of EPEG in Beta Thalassemia Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype
- Status
- COMPLETED
- Phase
- PHASE3
To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care
- Status
- COMPLETED
- Phase
- N/A
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia
- Status
- COMPLETED
- Phase
- PHASE3
Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients
- Status
- UNKNOWN
- Phase
- NA
Gene Therapy for Transfusion Dependent Beta-thalassemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2